Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
Status:
Recruiting
Trial end date:
2028-03-31
Target enrollment:
Participant gender:
Summary
This study is a multicentre, prospective, randomised trial, aims to evaluate the efficacy and
safety of Irinotecan Drug-Eluting Beads combined with regorafenib as the third-line treatment
for a patient with colorectal cancer liver metastases. The study is planned to enrolled 126
patients failing first- and second-line standard chemotherapy treatment.